Vasoplegic syndrome during liver transplantation

Anesthesia and Analgesia

Volumn 108, Issue 6, 2009, Pages 1941-1943

  Cao, Zhongping ^a,b   Gao, Yuqi ^a   Tao, Guocai ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE; NORADRENALIN; PHENYLEPHRINE; ANTIDOTE; VASOCONSTRICTOR AGENT;

ARTICLE; CHRONIC HEPATITIS; HEART OUTPUT; HEPATITIS B; HYPOTENSION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESUSCITATION; SHOCK; SYSTEMIC VASCULAR RESISTANCE; VASOPLEGIC SYNDROME; ADULT; BLOOD GAS ANALYSIS; CASE REPORT; DRUG EFFECT; ELECTROLYTE BALANCE; FEMALE; HEMODYNAMICS; HIGH OUTPUT HEART FAILURE; HUMAN; PEROPERATIVE COMPLICATION; PHYSIOLOGY; SYNDROME; TACHYCARDIA; VASCULAR RESISTANCE;

ADULT; ANTIDOTES; BLOOD GAS ANALYSIS; CARDIAC OUTPUT, HIGH; FEMALE; HEMODYNAMICS; HEPATITIS B; HUMANS; HYPOTENSION; INTRAOPERATIVE COMPLICATIONS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; METHYLENE BLUE; NOREPINEPHRINE; PHENYLEPHRINE; SYNDROME; TACHYCARDIA; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; WATER-ELECTROLYTE BALANCE;

EID: 66349117699     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181a286fc     Document Type: Article

References (19)

1. Shanmugam G. Vasoplegic syndrome-the role of methylene blue. Eur J Cardiothorac Surg 2005;28:705-10
2. Gomes WJ, Erlichman MR, Batista-Filho ML, Knobel M, Almeida DR, Carvalho AC, Catani R, Buffolo E. Vasoplegic syndrome after off-pump coronary artery bypass surgery. Eur J Cardiothorac Surg 2003;23:165-9
3. Levin RL, Degrange MA, Bruno GF, Del Mazo CD, Taborda DJ, Griotti JJ, Boullon FJ. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 2004;77:496-9
4. Gomes WJ, Carvalho AC, Palma JH, Teles CA, Branco JN, Silas MG, Buffolo E. Vasoplegic syndrome after open heart surgery. J Cardiovasc Surg 1998;39:619-23
5. Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-87
6. Egi M, Bellomo R, Langenberg C, Haase M, Haase A, Doolan L, Matalanis G, Seevenayagam S, Buxton B. Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: a systematic literature review. Ann Thorac Surg 2007;83:715-23
7. Holmes CL, Walley KR. Arginine vasopressin in the treatment of vasodilatory septic shock. Best Pract Res Clin Anaesthesiol 2008;22:275-86
8. Koelzow H, Gedney JA, Baumann J, Snook NJ, Bellamy MC. The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. Anesth Analg 2002;94:824-9
9. Ulukaya S, Alper I, Aydin U, Kilic M. Successful resuscitation of cardiac arrest due to postreperfusion syndrome during orthotopic liver transplantation: a case report. Transplant Proc 2007;39:3527-9
10. Hilmi I, Horton CN, Planinsic RM, Sakai T, Nicolau-Raducu R, Damian D, Gligor S, Marcos A. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl 2008;14:504-8
11. Arranz J, Soriano A, Garcia I, Concepcion MT, Navarro J, Arteaga A, Filella X, Bravo P, Barrera M, Escribano S, Jimenez A, Moneva E, Fernandez J, Varona A, Herrero E, Dominguez D. Effect of proinflammatory cytokines (IL-6, TNF-alpha, IL-1beta) on hemodynamic performance during orthotopic liver transplantation. Transplant Proc 2003;35:1884-7
12. Maring JK, Klompmaker IJ, Zwaveling JH, van Der Meer J, Limburg PC, Slooff MJ. Endotoxins and cytokines during liver transplantation: changes in plasma levels and effects on clinical outcome. Liver Transpl 2000;6:480-8
13. Kubala L, Ciz M, Vondracek J, Cizova H, Cerny J, Nemec P, Studenik P, Duskova M, Lojek A. Peri- and post-operative course of cytokines and the metabolic activity of neutrophils in human liver transplantation. Cytokine 2001;16:97-101
14. Ushakova IA, Vabishchevich AV. Hemodynamic disorders in liver transplantation and their correction. Anesteziol Reanimatol 2006;74-80
15. Pillay SP, Wynter C, Lynch S, Wall D, Balderson G, Strong R. Endotoxin levels in donors and recipients during orthotopic liver transplantation. Aust N Z J Surg 1997;67:187-91
16. Argenziano M, Chen JM, Choudhri AF, Cullinane S, Garfein E, Weinberg AD, Smith CR Jr, Rose EA, Landry DW, Oz MC. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 1998;116:973-80
17. Nygren A, Thoren A, Ricksten SE. Norepinephrine and intestinal mucosal perfusion in vasodilatory shock after cardiac surgery. Shock 2007;28:536-43
18. Dunser MW, Wenzel V, Mayr AJ, Hasibeder WR. Management of vasodilatory shock: defining the role of arginine vasopressin. Drugs 2003;63:237-56
19. Dunser MW, Westphal M. Arginine vasopressin in vasodilatory shock: effects on metabolism and beyond. Curr Opin Anaesthesiol 2008;21:122-7